Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
In this 5-months study, the response of patients to salbutamol at baseline will be compared with their response to treatment with indacaterol.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Diagnosis of COPD (moderate-to-severe as classified by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines, 2009) and:
Smoking history of at least 10 pack-years
Exclusion criteria
Other protocol-defined inclusion/exclusion criteria may apply
Primary purpose
Allocation
Interventional model
Masking
625 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal